October 09, 2018
Rose
A highly unusual response to my article on insurance obstacles to obtaining powerful new cholesterol-lowering drugs came from the very top: the leaders of one of the two companies making the drugs.
from Health https://ift.tt/2pKSyfo
October 09, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
$1 Billion in Government Coronavirus Payments Went to Dead People- ‘Feeling Like Death’: Inside a Houston Hospital Bracing for a Virus Peak
- Starbucks Barista Gets $87,000 in Donations After Customer’s Mask Complaint
- Dr. William Dement, Leader in Sleep Disorder Research, Dies at 91
- A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment